Blogs

ICYMI – Q2 2024 – SNMMI

Facet Attends SNMMI In June, Dr. Lisa Jenkins VanLuvanee attended the Society of Nuclear Medicine & Molecular Imaging (SNMMI) annual meeting.  SNMMI is an educational, scientific, research, and networking organization focus...

Read More

ICYMI – Q2 2024 – PET CMC Coalition

Facet Joins PET CMC Coalition In May, Facet joined the Coalition of PET Drug Manufacturers, a not-for-profit organization that seeks to help PET drug manufacturers to gain and maintain US marketing authorizations for PET drugs ...

Read More

Industry Focus Q2-2024: Chevron Deference

Supreme Court Overrules Chevron Deference; What Now? June 28, in a case known as Loperbright Enterprises v. Raimondo (Loperbright), the United States Supreme Court overturned a 40-year-old precedent known as Chevron deference. ...

Read More

Facet By The Numbers – Q1 2024

FACET BY THE NUMBERS Total ESG submissions to FDA Jan – Mar 2024:  over 30! Early-stage development highlights:  led 2 formal FDA meetings, over 25 IND amendments (e.g., new protocols/amendments, CMC updates, nonclinical study ...

Read More
QTLY Newsletter

FDA Round Up – Q1 2024

FDA ROUNDUP: FDA Urges Sponsors to Conduct Third Party Validations Prior to Submission – Since the start of 2024, there have been several high-profile cases in which unreliable, incorrect, and even fabricated data have be...

Read More
FDA Roundup
Go to Top